Roche and InterMune Reach Definitive Merger Agreement

Pictures

View all Roche and InterMune Reach Definitive Merger Agreement pictures

Roche announced that it has entered into a definitive merger agreement to acquire California-based biotechnology company InterMune for $74.00 per share in an all-cash transaction.

Edit item | Search at Amazon

Tags: Roche (1), Intermune (1), Idiopathic Pulmonary Fibrosis (1), Pirfenidone (1), Biotechnology Company (1), Respiratory Product Portfolio (1)

My tags:

Add tags


Condition
Added date
Private notes Only visible to you
or cancel